Y030-7401 Screening compound: N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]-2-phenoxybenzamide

Y030-7401 Screening compound: N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]-2-phenoxybenzamide
Y030-7401 Screening compound: N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]-2-phenoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y030-7401
N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]-2-phenoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y030-7401

Molecular Formula

C17H15N3O3S (C17 H15 N3 O3 S)

Compound Name

N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]-2-phenoxybenzamide

IUPAC name

N-[5-(methoxymethyl)-134-thiadiazol-2-yl]-2-phenoxybenzamide

SMILES

COCc1nnc(NC(c(cccc2)c2Oc2ccccc2)=O)s1

InChI

InChI=1S/C17H15N3O3S/c1-22-11-15-19-20-17(24-15)18-16(21)13-9-5-6-10-14(13)23-12-7-3-2-4-8-12/h2-10H,11H2,1H3,(H,18,20,21)

InChI Key

DAIFOTCQKMBYBJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03616231

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

341.39

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.356

Distribution Coefficient, logD

2.383

Water Solubility, LogSw

-4.00

Polar Surface Area

62.628

Acid Dissociation Constant (pKa)

6.48

Base Dissociation Constant (pKb)

-4.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.80

Y030-7401 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Cardiovascular Library (22201 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cardiovascular
  • Nervous system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with Y030-7401 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y030-7401?
Check Price and Availability of Y030-7401, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y030-7401 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y030-7401
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y030-7401
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y030-7401 available by request